Murat Kalayoglu - 02 Jan 2024 Form 4 Insider Report for Cartesian Therapeutics, Inc. (RNAC)

Role
Director, 10%+ Owner
Signature
/s/ Matthew Bartholomae, Attorney-in-Fact for Murat Kalayoglu
Issuer symbol
RNAC
Transactions as of
02 Jan 2024
Net transactions value
$0
Form type
4
Filing time
04 Jan 2024, 17:04:04 UTC
Previous filing
15 Nov 2023
Next filing
10 Apr 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RNAC Common Stock Award $0 +178,000 +69% $0.000000 435,739 02 Jan 2024 Direct F1
holding RNAC Common Stock 3,303,699 02 Jan 2024 by trust F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RNAC Stock Option (Right to Buy) Award $0 +228,000 $0.000000 228,000 02 Jan 2024 Common Stock 228,000 $0.6552 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit represents a contingent right to receive one share of common stock, which will vest in three equal annual installments so that the underlying shares will be fully vested on January 2, 2027.
F2 Shares are held in a trust (the "Trust") for the benefit of the reporting person's spouse and children. The reporting person's spouse is a trustee of the trust.
F3 This award will vest in 36 equal monthly installments, so that it shall be fully vested on January 2, 2027.

Remarks:

Exhibit 24 - Power of Attorney